These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19050545)

  • 1. A comprehensive review of patient-reported satisfaction with botulinum toxin type a for aesthetic procedures.
    Fagien S; Carruthers JDA
    Plast Reconstr Surg; 2008 Dec; 122(6):1915-1925. PubMed ID: 19050545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC
    Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction.
    De Boulle K; Fagien S; Sommer B; Glogau R
    Clin Interv Aging; 2010 Apr; 5():101-18. PubMed ID: 20458348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Systematic Review of Patient-Reported Outcomes for Cosmetic Indications of Botulinum Toxin Treatment.
    Wang J; Rieder EA
    Dermatol Surg; 2019 May; 45(5):668-688. PubMed ID: 30893170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Perceived Benefit in Facial Aesthetic Procedures: FACE-Q as a Tool to Study Botulinum Toxin Injection Outcomes.
    Chang BL; Wilson AJ; Taglienti AJ; Chang CS; Folsom N; Percec I
    Aesthet Surg J; 2016 Jul; 36(7):810-20. PubMed ID: 26780945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported benefit and satisfaction with botulinum toxin type A treatment of moderate to severe glabellar rhytides: results from a prospective open-label study.
    Stotland MA; Kowalski JW; Ray BB
    Plast Reconstr Surg; 2007 Oct; 120(5):1386-1393. PubMed ID: 17898617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Italian consensus report on the aesthetic use of onabotulinum toxin A.
    Bertossi D; Cavallini M; Cirillo P; Piero Fundarò S; Quartucci S; Sciuto C; Tonini D; Trocchi G; Signorini M
    J Cosmet Dermatol; 2018 Oct; 17(5):719-730. PubMed ID: 30091253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Glabellar Lines: A Meta-Analysis of Randomized, Placebo-Controlled, Double-Blind Trials.
    Guo Y; Lu Y; Liu T; Zhou Y; Yang P; Zhu J; Chen L; Yang Q
    Plast Reconstr Surg; 2015 Sep; 136(3):310e-318e. PubMed ID: 26313835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin injection for facial wrinkles.
    Small R
    Am Fam Physician; 2014 Aug; 90(3):168-75. PubMed ID: 25077722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D
    Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
    Duarte GS; Castelão M; Rodrigues FB; Marques RE; Ferreira J; Sampaio C; Moore AP; Costa J
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD004314. PubMed ID: 27782297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving patient retention after botulinum toxin type A treatment.
    White L; Tanzi EL; Alster TS
    Dermatol Surg; 2006 Feb; 32(2):212-5. PubMed ID: 16442041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie J; Wilson DI; Herbison GP; Wilson D
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005493. PubMed ID: 17636801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin for the treatment of strabismus.
    Rowe FJ; Noonan CP
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006499. PubMed ID: 22336817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the Facial Lines Treatment Satisfaction Questionnaire and initial results for botulinum toxin type A-treated patients.
    Cox SE; Finn JC; Stetler L; Mackowiak J; Kowalski JW
    Dermatol Surg; 2003 May; 29(5):444-9; discussion 449. PubMed ID: 12752509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing recent concerns in comparative studies of botulinum toxin type A.
    de Boulle K; de Almeida AT
    J Cosmet Laser Ther; 2010 Oct; 12(5):246-8. PubMed ID: 20825255
    [No Abstract]   [Full Text] [Related]  

  • 19. Aesthetic Treatment With Botulinum Toxin: Approaches Specific to Men.
    Green JB; Keaney TC
    Dermatol Surg; 2017 Nov; 43 Suppl 2():S153-S156. PubMed ID: 29064978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler.
    Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.